Function of molecular switch pinpointed in severe congenital neutropenia

Researchers have for the first time cleared an important hurdle to clarifying the molecular mechanics behind Severe Congenital Neutropenia (SCN), a deadly disease characterized by a deficiency of neutrophils – a type of mature white blood cell important to fighting infection and disease. A research team led by Cincinnati Children’s Hospital Medical Center reports in the March 14 Immunity the first evidence of how a specific genetic mutation found in humans with SCN blocks neutrophil development in mouse bone marrow cells.

The finding is expected to give researchers a way to more effectively study SCN, which puts children at increased risk of developing bacterial and fungal infections and acute myelogenous leukemia.

“Our discovery that humans and mice have a shared pathway for the development of neutrophils should provide new avenues for understanding the molecular basis of SCN associated with other genetic mutations,” said H. Leighton Grimes, Ph.D., a researcher in the Division of Immunology at Cincinnati Children’s and lead author of the study. “It’s important that we find clues for developing possible treatments to help children with this disease.”

The research team studied a gene called Growth Factor Independent-1 (GFI1), which is expressed in bone marrow stem cells and known to help control the growth and differentiation of blood cells, including those that become neutrophils. When it works normally, GFI1 promotes the formation of neutrophils by blocking the development of macrophages, the default differentiation pathway. Specifically, GFI1 acts as a molecular switch to moderate the function of another gene, Colony Stimulating Factor-1 (CSF1), which tells marrow stem cells to form macrophage white blood cells instead of neutrophils.

Dr. Grimes and his colleagues discovered that GFI1’s ability to act as a rate-limiting molecular switch is compromised by a genetic error found in patients with SCN, a mutation known as GFI1N382S. When the mutant form of GFI1 found in SCN patients interferes with GFI1’s switching function, it results in deregulated expression of CSF1, an overproduction of macrophages and blocks to the formation of neutrophils. The researchers also found that blocking the function or expression of CSF1 allowed mutant GFI1cells to become neutrophils.

“In SCN patients with mutations in GFI1, it’s as though the switch that allows the formation of neutrophils is always in the off position, and the bone marrow stem cells are constantly receiving the message to become macrophages,” said Dr. Grimes. “The ability to produce both types of blood cells is important to fight off infection.”

Pursuing the GFI1-CSF1 molecular pathway also led to the study’s other milestone, as Dr. Grimes and his co-investigators were able to develop a mouse model for SCN that allows future studies of possible therapies. The most common known genetic mutation found in humans with SCN is in a gene called ELA2, which encodes a protein that cleaves other proteins. Unfortunately, previous research has shown that mice with mutated or deleted ELA2 do not develop SCN, leaving researchers without a workable model of SCN for study. The team used this problem as an opportunity. Because ELA2 is also regulated by GFI1, Dr. Grimes and his colleagues decided to take a step back in the molecular process to further study the influence of GFI1. Their focus on GFI1 also allowed them incorporate their previous research that identified a family of SCN patients, all of whom had the GFI1N382S mutation.

SNC is a rare inherited autosomal recessive disease. The current treatment for SCN includes recombinant Granulocyte-colony stimulating factor (GCSF), which increases the formation and proliferation of white blood cells for most patients. However, the treatment still fails to correct the underlying gene defects behind the disease and does not work in all patients. There is also concern that GCSF treatment may help induce the development of leukemia, highlighting the need of different treatment options. Besides being prone to infection or acute myelogenous leukemia, children with SCN can contract the bone marrow disorder, myelodysplasia, in which patients have ineffective production of blood cells and are at higher risk of developing acute myelogenous leukemia.

Source: Cincinnati Children's Hospital Medical Center

Related stories:

Study identifies food-related clock in the brain
In investigating the intricacies of the body’s biological rhythms, scientists at Beth Israel Deaconess Medical Center (BIDMC) have discovered the existence of a “food-related clock” which can supersede the “light-based” master clock that serves as the body’s primary timekeeper.
Mouse vision has a rhythm all its own
In the eyes of mammals, visual information is processed on a daily schedule set within the eyes themselves—not one dictated by the brain, according to a new report in the August 24 issue of the journal Cell, a publication of Cell Press. The researchers found in mice that the eyes’ normal rhythmic response to light requires only that a molecular "clock" inside the retina go on ticking. The retina is a layer of nerve tissue covering the back of the eyeball, which is often likened to the film in a camera; without it, images can't be captured.
Study reveals little-known cell networks vital to circadian rhythm
Circadian rhythm is the basic 24-hour cycle that involves various behaviors, including sleeping and eating, in all living organisms. In mammals, the circadian clock is organized hierarchically in a series of multiple oscillators. At the top of this hierarchy, the suprachiasmatic nucleus (SCN), a region of the brain that is the body"s main rhythmic regulator, integrates light information from the eyes and coordinates peripheral oscillators throughout the body.
Central and peripheral signals set the circadian liver clock
Anyone who has experienced jet lag will understand the importance of a smooth-running circadian clock. Crossing time zones decouples our biological rhythms from the natural cycle of light and dark we’re used to. We perceive light cues through retinal photoreceptors that relay signals to the suprachiasmatic nucleus (SCN) in the brain. "Phase adjustments" in peripheral tissues ensure that each clock follows the same schedule.
Mice have biological clock for smell
Biologists at Washington University in St. Louis have discovered a large biological clock in the smelling center of mice brains and have revealed that the sense of smell for mice is stronger at night, peaking in evening hours and waning during day light hours.
Protein shown to rally biological clock
A biologist at Washington University in St. Louis and his collaborators have identified the factor in mammalian brain cells that keeps cells in synchrony so that functions like the wake-sleep cycle, hormone secretion and loco motor behaviors are coordinated daily over a 24-hour period.
Separating morning and evening in the circadian clock of mammals
Work by researchers at the universities of Aberdeen and Nottingham suggest an anatomical basis for the adaptation of the mammalian circadian clock to changing day-length.
Endogenous circadian clocks ensure that temporal patterns of physiology and behavior predict environmental changes determined by the Earth’s rotation and orbit of the Sun. Such clocks are synchronized by the daily light-dark cycle.
Constant Lighting May Disrupt Development of Preemie's Biological Clocks
Keeping the lights on around the clock in neonatal intensive care units may interfere with the development of premature babies’ biological clocks. That is the suggestion of a new study reported in the Aug. 21 issue of the journal Pediatric Research.

News discussion:

Medicine & Health news